De novo expression of dopamine D2 receptors on microglia after stroke

Jojanneke H J Huck1, Dorette Freyer2, Chotima Böttcher1

  • 1Laboratory of Molecular Psychiatry, Department of Neuropsychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Insights

Dopamine receptors, particularly the D2 receptor (D2R), are expressed on microglia during neuroinflammation. Dopamine D2/3R agonists may modulate microglial immune responses in the brain.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Dopamine is a key neurotransmitter and immune modulator in the brain.
  • Microglia are the primary immune cells in the central nervous system.
  • Dopamine receptors are implicated in various neurological functions.

Purpose of the Study:

  • To investigate the expression of dopamine receptors on murine microglia.
  • To determine the role of dopamine D2 receptor (D2R) in microglia during neuroinflammation.

Main Methods:

  • Primary microglia cultures were used to assess dopamine receptor expression.
  • Immunohistochemistry and transgenic mice (GFP under Drd2 promoter) were employed.
  • Cerebral ischemia model was used to induce neuroinflammation and study D2R expression in vivo.

Main Results:

  • Cultured microglia express dopamine D1, D2, D3, D4, and D5 receptors.
  • D2R is not detected on microglia in healthy brains but is induced after cerebral ischemia.
  • D2R is expressed on activated microglia and infiltrating macrophages in the ischemic brain.
  • Pramipexole (D2/3R agonist) enhanced nitrite secretion by microglia.

Conclusions:

  • Dopamine receptors, including D2R, are expressed on microglia, particularly under inflammatory conditions.
  • Dopamine signaling may modulate microglial function during neuroinflammation.
  • D2R expression on microglia could represent a therapeutic target for neuroinflammatory diseases.

Related Concept Videos